Report cover image

NA Pharmacogenetic Testing Market - Industry Trends and Forecast to 2034

Publisher Data Bridge Market Research
Published Oct 01, 2023
Length 173 Pages
SKU # DAABD18360507

Description

NA Pharmacogenetic Testing Market - Industry Trends and Forecast to 2034


The North America pharmacogenetic testing market is expected to reach USD 5,318.02 million by 2030 from USD 2,723.12 million in 2022, growing at a CAGR of 8.9% during the forecast period of 2023 to 2030.

Market Segmentation
North America Pharmacogenetic Testing Market, By Type (Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, and Single Gene Tests), Gene Type (CYP2C19, CYP2D6, CYP2C9 AND VKORC1, CYP1A2, HLA-B*1502, HLA-B*5701, CYP2D, OPRM1, ONCOTYPE DX AND MAMMAPRINT, DRD3, D4D4, SLC6A4, HTR2A/C, TMPT, and Others), Drug Type (Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, and Over-the-Counter Medications), Sample (Blood and Saliva), Therapeutic Area (Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology & Hypersensitivity, Dermatology, Gynecology, Oncology, Neurology, and Others), Application (Clinical Practice, Drug Development, and Drug Regulation), End User (Healthcare Providers, Pharmaceutical & Biotechnology Companies, Research Centres and Academic Institutes, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, and Direct-to-Customer Services), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2030

Overview of Global Pharmacogenetic Testing Market Dynamics

Driver
• Rapid technological advancement and miniaturization
Restrain

• Environment and health concerns
Opportunity

• Rising research and development and innovative technologies

Market Players

Some of the major market players operating in the North America pharmacogenetic testing market are:

• Thermo Fisher Scientific
• Illumina, Inc
• QIAGEN
• Sonic Healthcare
• BGI

Table of Contents

173 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of North America Pharmacogenetic Testing Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Dbmr Market Position Grid
2.7 Multivariate Modelling
2.8 Type Lifeline Curve
2.9 Market End User Coverage Grid
2.10 Secondary Sources
2.11 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter’sfive Forces
4.3 Industry Insights And Strategic Analysis
5 Market Overview
5.1 Drivers
5.1.1 Increasing Adoption Of Personalized Medicine
5.1.2 Advancements In Genomic Technologies
5.1.3 Increasing Chronic And Complex Diseases
5.1.4 Role Of Pharmacogenetic Testing In Drug Discovery And Development
5.2 Restraints
5.2.1 Dependency On The Medical And Genomic Expert For Result Interpretation
5.2.2 Ethical And Privacy Concerns Associated With Pharmacogenetic Testing 49 
5.3 Opportunities
5.3.1 Integration With Electronic Health Records (Ehrs)
5.3.2 Artificial Intelligence (Ai) And Machine Learning Integration In Healthcare
5.4 Challenges
5.4.1 Challenges In Clinical Implementation Of Pharmacogenetics
5.4.2 Complexity Associated With Pharmacogenetic Testing Results
6 North America Pharmacogenetic Testing Market, By Type
6.1 Overview
6.2 Whole Genome Sequencing
6.2.1 Next Generation Sequencing (Ngs)
6.2.2 Sanger Sequencing
6.3 Whole Exome Sequencing
6.3.1 Next Generation Sequencing (Ngs)
6.3.2 Sanger Sequencing
6.4 Array-based Tests
6.4.1 Glass Slide Arrays
6.4.2 In—situ Synthesized Arrays
6.4.3 Self Assembled Arrays
6.5 Single Gene Tests
6.5.1 Next Generation Sequencing (Ngs)
6.5.2 Sanger Sequencing
7 North America Pharmacogenetic Testing Market, By Gene Type
7.1 Overview
7.2 Cyp2c19
7.3 Cyp2d6
7.4 Cyp2c9 And Vkorc1
7.5 Cyp1a2
7.6 Hla-b*1502
7.7 Hla-b*5701
7.8 Cyp2d
7.9 Oprm1
7.10 Oncotype Dx* And Mammaprint
7.11 Drd3
7.12 D4d4
7.13 Slc6a4
7.14 Htr2a/C
7.15 Tmpt
7.16 Others
8 North America Pharmacogenetic Testing Market, By Drug Type
8.1 Overview
8.2 Prescription Drugs
8.3 Nutraceuticals
8.4 Recreational Drugs
8.5 Herbal Supplements
8.6 Vitamins
8.7 Over-the-counter Medications
9 North America Pharmacogenetic Testing Market, By Sample
9.1 Overview
9.2 Blood
9.3 Saliva
10 North America Pharmacogenetic Testing Market, By Therapeutic Area
10.1 Overview
10.2 Cardiology
10.3 Gastroenterology
10.4 Anesthesiology
10.5 Genomics
10.6 Endocrinology
10.7 Immunology & Hypersensitivity
10.8 Dermatology
10.9 Gynecology
10.10 Oncology
10.11 Neurology
10.12 Others
11 North America Pharmacogenetic Testing Market, By Application
11.1 Overview
11.2 Clinical Practice
11.2.1 Side Effects
11.2.2 Drug Effectiveness
11.2.3 Dosage
11.3 Drug Development
11.3.1 Drug Effectiveness
11.3.2 Dosage
11.3.3 Side Effects 100 
11.4 Drug Regulation
11.4.1 Side Effects
11.4.2 Drug Effectiveness
11.4.3 Dosage
12 North America Pharmacogenetic Testing Market, By End User
12.1 Overview
12.2 Healthcare Providers
12.3 Pharmaceutical & Biotechnology Companies
12.4 Research Centres And Academic Institutes
12.5 Others
13 North America Pharmacogenetic Testing Market, By Distribution Channel
13.1 Overview
13.2 Hospital Pharmacy
13.3 Retail Pharmacies
13.4 Mail-order Pharmacies
13.5 Direct-to-customer Services
14 North America Pharmacogenetic Testing Market, By Region
14.1 North America
15 North America Pharmacogenetic Testing Market: Company Landscape
15.1 Company Share Analysis: North America
16 Swot Analysis
17 Company Profile
17.1 Thermo Fisher Scientific Inc.
17.1.1 Company Snapshot
17.1.2 Revenue Analysis
17.1.3 Company Share Analysis
17.1.4 Product Portfolio
17.1.5 Recent Developments
17.2 Illumina, Inc.
17.2.1 Company Snapshot
17.2.2 Revenue Analysis
17.2.3 Company Share Analysis
17.2.4 Product Portfolio
17.2.5 Recent Development 144 
17.3 Qiagen
17.3.1 Company Snapshot
17.3.2 Revenue Analysis
17.3.3 Company Share Analysis
17.3.4 Product Portfolio
17.3.5 Recent Development
17.4 Sonic Healthcare
17.4.1 Company Snapshot
17.4.2 Revenue Analysis
17.4.3 Company Share Analysis
17.4.4 Product Portfolio
17.4.5 Recent Development
17.5 Bgi
17.5.1 Company Snapshot
17.5.2 Company Share Analysis
17.5.3 Product Portfolio
17.5.4 Recent Development
17.6 23andme, Inc
17.6.1 Company Snapshot
17.6.2 Revenue Analysis
17.6.3 Product Portfolio
17.6.4 Recent Development
17.7 Dynamic Dna Laboratories
17.7.1 Company Snapshot
17.7.2 Product Portfolio
17.7.3 Recent Development
17.8 Eurofins Scientific (2022)
17.8.1 Company Snapshot
17.8.2 Revenue Analysis
17.8.3 Product Portfolio
17.8.4 Recent Development
17.9 Genewix (A Subsidiary Of Azenta Life Science)
17.9.1 Company Snapshot
17.9.2 Product Portfolio
17.9.3 Recent Development
17.10 Luminex Corporation (A Subsidiary Of Diasorin)
17.10.1 Company Snapshot
17.10.2 Product Portfolio
17.10.3 Recent Development
17.11 Md Labs
17.11.1 Company Snapshot
17.11.2 Product Portfolio
17.11.3 Recent Development
17.12 Myriad Genetics, Inc.
17.12.1 Company Snapshot
17.12.2 Revenue Analysis
17.12.3 Product Portfolio
17.12.4 Recent Developments
17.13 Oneome
17.13.1 Company Snapshot
17.13.2 Product Portfolio
17.13.3 Recent Development
17.14 Pacbio
17.14.1 Company Snapshot
17.14.2 Revenue Analysis
17.14.3 Product Portfolio
17.14.4 Recent Development
17.15 Perkinelmer Inc.
17.15.1 Company Snapshot
17.15.2 Revenue Analysis
17.15.3 Product Portfolio
17.15.4 Recent Development
17.16 Pgxt
17.16.1 Company Snapshot
17.16.2 Product Portfolio
17.16.3 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables
Table 1 North America Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 2 North America Whole Genome Sequencing In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 3 North America Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 4 North America Whole Exome Sequencing In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 5 North America Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 6 North America Array-based Tests In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 7 North America Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 8 North America Single Gene Tests In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 9 North America Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 10 North America Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 11 North America Cyp2c19 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 12 North America Cyp2d6 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 13 North America Cyp2c9 And Vkorc1 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 14 North America Cyp1a2 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 15 North America Hla-b*1502 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 16 North America Hla-b*5701 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 17 North America Cyp2d In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 18 North America Oprm1 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 19 North America Oncotype Dx* And Mammaprint In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 20 North America Drd3 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 21 North America D4d4 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 22 North America Slc6a4 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 23 North America Htr2a/C In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 24 North America Tmpt In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 25 North America Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 26 North America Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 27 North America Prescription Drugs In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 28 North America Nutraceuticals In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 29 North America Recreational Drugs In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 30 North America Herbal Supplements In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 31 North America Vitamins In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 32 North America Over-the-counter Medications In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 33 North America Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 34 North America Blood In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 35 North America Saliva In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 36 North America Pharmacogenetic Testing Market, By Therpaeutic Area, 2021-2030 (Usd Million)
Table 37 North America Cardiology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 38 North America Gastroenterology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 39 North America Anesthesiology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 40 North America Genomics In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 41 North America Endocrinology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 42 North America Immunology & Hypersensitivity In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 43 North America Dermatology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 44 North America Gynecology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 45 North America Oncology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 46 North America Neurology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 47 North America Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 48 North America Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 49 North America Clinical Practice In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 50 North America Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 51 North America Drug Development In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 52 North America Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 53 North America Drug Regulation In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 54 North America Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 55 North America Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 56 North America Healthcare Providers In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 57 North America Pharmaceutical & Biotechnology Companies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 58 North America Research Centres And Academic Institutes In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 59 North America Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 60 North America Pharmacogenetic Testing Market, By Distribution Channel, 2020-2030 (Usd Million)
Table 61 North America Hospital Pharmacy In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 62 North America Retail Pharmacies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 63 North America Mail-order Pharmacies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 64 North America Direct-to-customer Services In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 65 North America Pharmacogenetic Testing Market, By Country, 2021-2030 (Usd Million)
Table 66 North America Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 67 North America Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 68 North America Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 69 North America Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 70 North America Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 71 North America Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 72 North America Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 73 North America Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 74 North America Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 75 North America Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 76 North America Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 77 North America Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 78 North America Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 79 North America Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 80 North America Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 81 U.S. Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 82 U.S. Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 83 U.S. Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 84 U.S. Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 85 U.S. Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 86 U.S. Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 87 U.S. Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 88 U.S. Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 89 U.S. Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 90 U.S. Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 91 U.S. Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 92 U.S. Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 93 U.S. Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 94 U.S. Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 95 U.S. Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 96 Canada Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 97 Canada Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 98 Canada Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 99 Canada Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 100 Canada Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 101 Canada Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 102 Canada Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 103 Canada Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 104 Canada Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 105 Canada Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 106 Canada Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 107 Canada Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 108 Canada Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 109 Canada Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 110 Canada Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 111 Mexico Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 112 Mexico Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 113 Mexico Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 114 Mexico Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 115 Mexico Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 116 Mexico Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 117 Mexico Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 118 Mexico Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 119 Mexico Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 120 Mexico Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 121 Mexico Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 122 Mexico Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 123 Mexico Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 124 Mexico Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 125 Mexico Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
List Of Figures
Figure 1 North America Pharmacogenetic Testing Market: Segmentation
Figure 2 North America Pharmacogenetic Testing Market: Data Triangulation
Figure 3 North America Pharmacogenetic Testing Market: Droc Analysis
Figure 4 North America Pharmacogenetic Testing Market: North America Vs Regional Market Analysis
Figure 5 North America Pharmacogenetic Testing Market: Company Research Analysis
Figure 6 North America Pharmacogenetic Testing Market: Interview Demographics
Figure 7 North America Pharmacogenetic Testing Market: Dbmr Market Position Grid
Figure 8 North America Pharmacogenetic Testing Market: Market End User Coverage Grid
Figure 9 North America Pharmacogenetic Testing Market: Segmentation
Figure 10 Increasing Adoption Of Personalized Medicine Is Driving The Growth Of The North America Pharmacogenetic Testing Market In The Forecast Period Of 2023 To 2030
Figure 11 Whole Genome Sequencing Segment Is Expected To Account For The Largest Share Of The North America Pharmacogenetic Testing Market In 2023 & 2030
Figure 12 Drivers, Restraints, Opportunities, And Challenges Of North America Pharmacogenetic Testing Market
Figure 13 North America Pharmacogenetic Testing Market: By Type, 2022
Figure 14 North America Pharmacogenetic Testing Market: By Type, 2023-2030 (Usd Million)
Figure 15 North America Pharmacogenetic Testing Market: By Type, Cagr (2023-2030)
Figure 16 North America Pharmacogenetic Testing Market: By Type, Lifeline Curve
Figure 17 North America Pharmacogenetic Testing Market: By Gene Type, 2022
Figure 18 North America Pharmacogenetic Testing Market: By Gene Type, 2023-2030 (Usd Million)
Figure 19 North America Pharmacogenetic Testing Market: By Gene Type, Cagr (2023-2030)
Figure 20 North America Pharmacogenetic Testing Market: By Gene Type, Lifeline Curve
Figure 21 North America Pharmacogenetic Testing Market: By Drug Type, 2022
Figure 22 North America Pharmacogenetic Testing Market: By Drug Type, 2023-2030 (Usd Million)
Figure 23 North America Pharmacogenetic Testing Market: By Drug Type, Cagr (2023-2030)
Figure 24 North America Pharmacogenetic Testing Market: By Drug Type, Lifeline Curve
Figure 25 North America Pharmacogenetic Testing Market: By Sample, 2022
Figure 26 North America Pharmacogenetic Testing Market: By Sample, 2023-2030 (Usd Million)
Figure 27 North America Pharmacogenetic Testing Market: By Sample, Cagr (2023-2030)
Figure 28 North America Pharmacogenetic Testing Market: By Sample, Lifeline Curve
Figure 29 North America Pharmacogenetic Testing Market: By Therapeutic Area, 2022
Figure 30 North America Pharmacogenetic Testing Market: By Therapeutic Area, 2023-2030 (Usd Million)
Figure 31 North America Pharmacogenetic Testing Market: By Therapeutic Area, Cagr (2023-2030)
Figure 32 North America Pharmacogenetic Testing Market: By Therapeutic Area, Lifeline Curve
Figure 33 North America Pharmacogenetic Testing Market: By Application, 2022
Figure 34 North America Pharmacogenetic Testing Market: By Application, 2023-2030 (Usd Million)
Figure 35 North America Pharmacogenetic Testing Market: By Application, Cagr (2023-2030)
Figure 36 North America Pharmacogenetic Testing Market: By Application, Lifeline Curve
Figure 37 North America Pharmacogenetic Testing Market: By End User, 2022
Figure 38 North America Pharmacogenetic Testing Market: By End User, 2023-2030 (Usd Million)
Figure 39 North America Pharmacogenetic Testing Market: By End User, Cagr (2023-2030)
Figure 40 North America Pharmacogenetic Testing Market: By End User, Lifeline Curve
Figure 41 North America Pharmacogenetic Testing Market: By Distribution Channel, 2022
Figure 42 North America Pharmacogenetic Testing Market: By Distribution Channel, 2023-2030 (Usd Million)
Figure 43 North America Pharmacogenetic Testing Market: By Distribution Channel, Cagr (2023-2030)
Figure 44 North America Pharmacogenetic Testing Market: By Distribution Channel, Lifeline Curve
Figure 45 North America Pharmacogenetic Testing Market: Snapshot (2022)
Figure 46 North America Pharmacogenetic Testing Market: Company Share 2022 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us